Pharma-Bio 2Q14 Update: $9 Billion in Project Starts Reflects 91% Gain in Industry Capital Investment
Pharma-Bio 2Q14 Update: $9 Billion in Project Starts Reflects 91% Gain in Industry Capital Investment
Attachment: Pharma-Biotech 2Q14
SUGAR LAND--April 17, 2014--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--When June 2014 draws to a close, the Pharmaceutical-Biotech Industry is forecast to have launched nearly $9 billion worth of North American capital and maintenance projects during the previous three months. The stunning number reflects a 91% increase over last year's figures.
Other companies featured: Emergent Biosolutions (NYSE:EBS), Endo Pharmaceuticals (NASDAQ:ENDP)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Food, Pharma Lift Kansas to $3 Billion in Projects Under Construction
- Kansas Sees More than $3.8 Billion in Projects Under Construction
- U.S. Power Project Spending Index Up $11.6 Billion Year Over Year in August
- McCarthy Building Companies at Work on $3.45 Billion in Projects
- M.A. Mortenson's $7 Billion in Active Projects Fueled by Windfarms, Enhance...
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
